Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Spine Wave raises $45 million: Spinal implant developer Spine Wave raises $45 million in a private placement to support expansion of its U.S. sales force and global distribution network, as well as R&D efforts and clinical trials, the firm says. Shelton, Conn.-based Spine Wave's U.S. offerings include the StaXx XD expandable polyetheretherketone (PEEK) spacer for vertebral body replacement and the CapSure PS top loading pedicle screw system for treating degeneration, tumor, or trauma of the thoracolumbar spine. Outside the United States the firm also offers the StaXx FX minimally invasive system for repairing vertebral compression fractures, and the NuCore injectable nucleus for early-stage degenerative disc disease. Founded in 2001 by former execs of spinal device powerhouse Sofamor Danek, privately held Spine Wave's latest financing round was led by Compass Global Fund...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel